Edition:
United States

Recro Pharma Inc (REPH.OQ)

REPH.OQ on NASDAQ Stock Exchange Capital Market

11.49USD
20 Apr 2018
Change (% chg)

$-0.01 (-0.09%)
Prev Close
$11.50
Open
$11.41
Day's High
$11.57
Day's Low
$11.12
Volume
46,342
Avg. Vol
50,310
52-wk High
$12.20
52-wk Low
$5.85

Chart for

About

Recro Pharma, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing products for hospitals and ambulatory care settings that is developing non-opioid products for treatment of serious acute pain. The Company's lead product candidate is an injectable form of meloxicam. Its product... (more)

Overall

Beta: -0.75
Market Cap(Mil.): $222.89
Shares Outstanding(Mil.): 19.40
Dividend: --
Yield (%): --

Financials

  REPH.OQ Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -2.21 -- --
ROI: -27.84 -0.74 13.19
ROE: -83.97 -2.80 15.00

BRIEF-Recro Pharma Inc Reports Year End 2017 Financial Results

* RECRO PHARMA INC - FOR 2018, COMPANY EXPECTS REVENUE GENERATED FROM ITS CDMO DIVISION TO BE APPROXIMATELY $70 MILLION

Feb 27 2018

BRIEF-Recro Pharma Estimates Cash And Cash Equivalents About $64 Mln As Of Dec 31

* RECRO PHARMA - ESTIMATES THAT AS OF DEC 31, 2017, CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $64.0 MILLION Source text for Eikon: (http://bit.ly/2nOPGN7) Further company coverage:

Feb 07 2018

BRIEF-Recro Pharma - ‍Ryan Lake Promoted To CFO

* RECRO PHARMA INC - ‍RYAN D. LAKE HAS BEEN PROMOTED TO CHIEF FINANCIAL OFFICER​ Source text for Eikon: Further company coverage:

Jan 03 2018

BRIEF-Recro Pharma Says Entered Into A Sales Agreement With Cowen And Co‍​

* RECRO PHARMA INC - ENTERED INTO A SALES AGREEMENT WITH COWEN AND COMPANY‍​

Dec 29 2017

BRIEF-Recro Pharma secures $100 million credit facility

* Recro Pharma Inc - ‍has secured a $100 million credit facility from funds managed by Athyrium Capital Management, LP​

Nov 20 2017

BRIEF-Recro Pharma reports Q3 revenue $17.1 million

* Recro Pharma Inc - ‍Raising its guidance for 2017 revenue from a range of $60-$63 million to $65 million​

Nov 09 2017

Earnings vs. Estimates